CIK 0001447028
- Non-accelerated filer
- Smaller reporting company
Arbutus Biopharma Corp
Sign in to watch- Ticker
- ABUS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980597776
- Phone
- +1 604-419-3200
- Business address
- 701 VETERANS CIRCLE, WARMINSTER, PA, 18974
- Former names
- TEKMIRA PHARMACEUTICALS CORP, TEKMIRA PHARMACEUTICALS Corp
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4/A Open-market sale Chief Scientific Officer sold 4,250 shares at $9.51 ($40,436)
- 4 Open-market sale Chief Scientific Officer sold 4,250 shares at $9.51 ($40,436)
- 4 Open-market sale Chief Scientific Officer sold 10,000 shares at $10.00 ($100,000)
- 4 Open-market sale Chief Scientific Officer sold 20,000 shares at an average $8.68 ($173,560)
- 4 Open-market sale Chief Scientific Officer sold 20,000 shares at an average $8.20 ($164,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Option exercise President & CEO acquired 27,007 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 8 of 14 · 274 filings